Markets:

Overview

News

Currencies

International

Treasuries

Acumen Pharmaceuticals, Inc. - Common Stock (NQ:ABOS)

2.500 +0.100 (+4.17%)

Streaming Delayed Price Updated: 3:08 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Acumen Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

A Good Week For The Market But A Pause In The Biotech Rally ↗

May 22, 2023

Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗

May 18, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In Q2 ↗

May 10, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Earnings Outlook For Acumen Pharmaceuticals ↗

May 08, 2023

Via Benzinga

Earnings Preview For Acumen Pharmaceuticals ↗

March 24, 2023

Via Benzinga

Acumen Pharmaceuticals's Earnings: A Preview ↗

March 24, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

December 26, 2022

Via Benzinga

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

5 Value Stocks In The Healthcare Sector ↗

March 27, 2023

Via Benzinga

Earnings Scheduled For March 27, 2023 ↗

March 27, 2023

Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 14, 2022

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...

Via Benzinga

Earnings Preview: Acumen Pharmaceuticals ↗

November 11, 2022

Acumen Pharmaceuticals (NASDAQ:ABOS) is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement. Analysts estimate that Acumen...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 24, 2022

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 12, 2022

Gainers

Via Benzinga

How Is The Market Feeling About Acumen Pharmaceuticals? ↗

October 12, 2022

Acumen Pharmaceuticals's (NASDAQ:ABOS) short percent of float has risen 237.39% since its last report. The company recently reported that it has 2.36 million shares sold short, which is 7.76% of all...

Via Benzinga

RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday ↗

October 05, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Bank of America To $36? Plus This Analyst Slashes PT On Citigroup ↗

October 05, 2022

Morgan Stanley cut Bank of America Corporation (NYSE: BAC) price target from $40 to $36. Bank of America shares fell 2.4% to $31.62 on Wednesday.

Via Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

Nasdaq Surges Over 150 Points; Gold Rises 2% ↗

September 28, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 28, 2022

Gainers

Via Benzinga

Why Is Prothena (PRTA) Stock Up 75% Today? ↗

September 28, 2022

Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company.

Via InvestorPlace

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

Why Is Acumen (ABOS) Stock Up 95% Today? ↗

September 28, 2022

Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company.

Via InvestorPlace

Dow Jumps 300 Points; Crude Oil Rises Sharply ↗

September 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.

Via Benzinga

Why Acumen Pharmaceuticals Stock Is Soaring Today ↗

September 28, 2022

Acumen Pharmaceuticals Inc (NASDAQ: ABOS) shares are trading higher Wednesday after Biogen Inc (NASDAQ: BIIB) and Eisai Co (Pink:

Via Benzinga

US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗

September 28, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 28, 2022

Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Acumen Pharmaceuticals, Inc. - Common Stock (NQ:ABOS)

Headline News about Acumen Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today